Login to Your Account

Neurocrine Snares $75M CEFF to Hunt for Products to License

By Catherine Hollingsworth

Thursday, September 17, 2009
Neurocrine Biosciences Inc. has secured a commitment from Kingsbridge Capital Ltd. to purchase shares in the company through a warrant-free equity financing that would provide up to $75 million over three years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription